Litigation

PhRMA v. Brown

Date Filed: December 8, 2017
Status: Pending
District Court: Eastern District of California – 2:17-at-01323
Nature of Suit: Pharma Legislation Challenge
Defendant Type: State
Plaintiff Type: Private
Court Document: http://phrma-docs.phrma.org/files/dmfile/sb17-complaint.pdf

PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, and the Due Process Clause. SB 17, which Gov. Jerry Brown signed 10/9/17, requires pharmaceutical companies to notify insurers and government health plans 60 days in advance of a price increase above a certain threshold and provide a rationale for it.


Associated Legislation:

SB 17
Introduced:    Status: Passed
Prescription Drug Pricing – Notification: This bill would state the intent of the Legislature to enact legislation requiring public and private purchasers of health care and health care coverage be given advance notice of price …